跳至主要内容
临床试验/NCT05626504
NCT05626504进行中(未招募)不适用

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

King's College Hospital NHS Trust1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50
试验地点
1
主要终点
Evaluate 30-day morbidity rates

研究概览

简要总结

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients treated with Pipeline Embolization Device with Vantage Technology (PEDV)
  • MRA and/or DSA (or tomographic angiography) available for follow up

排除标准

  • Insufficient background data available e.g., to determine size of aneurysm and pipeline device
  • PEDV used for causes other than aneurysms, e.g., fistulas and dissection.

结局指标

主要结局

Evaluate 30-day morbidity rates

时间窗: Done at 30 days post procedural

We will evaluate short term clinical outcome in the form of morbidity rates 30 days after the procedure

Evaluate 30-day mortality rates

时间窗: Done at 30 days post procedural

We will evaluate short term clinical outcome in the form of mortality rates 30 days after the procedure

次要结局

  • Evaluate 1-year morbidity rates(Done at >30days up to 1 year post procedural)
  • Evaluate 1-year mortality rates(Done at >30days up to 1 year post procedural)

研究者

发起方
King's College Hospital NHS Trust
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验